Search Login Register
Mobility Limitation
(Difficulty Walking)
Summary
64
relevant articles (1 outcomes,
6 trials/studies)
found for this Disease
Description:
Difficulty in walking from place to place.
Also Known As:
Difficulty Walking; Ambulatory Difficulty; Difficulty Ambulation; Limitation, Mobility; Mobility Limitations Show All >>
Key Drugs and Agents for Mobility Limitation
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Silicon Dioxide (Sand)
:
1 outcome in 1 result
: IBA
-
hydroquinone (Black and White)
:
2 studies in 2 results
:
FDA 1
-
Lipoproteins (Lipoprotein)
:
1 study in 1 result
: IBA
-
oxidized low density lipoprotein
:
1 study in 1 result
: IBA
-
Interleukin-6 (Interleukin 6)
:
4 results
: IBA
-
M-2 protocol (M 2)
:
3 results
: IBA
-
Carbon Monoxide
:
2 results
: IBA
-
TANDEM
:
2 results
: IBA
-
Durapatite (Hydroxylapatite)
:
1 result
: IBA
-
Paclitaxel (Taxol)
:
1 result
:
FDA 12
Generic
Show All >>
Diseases Related to Mobility Limitation
-
Pain (Aches)
-
Hypesthesia (Numbness)
-
Dizziness (Lightheadedness)
-
Neoplasms (Cancer)
-
Stroke (Strokes)
Show All >>
Key Therapies for Mobility Limitation
Efficacy Chart >>
-
Activities of Daily Living (ADL)
:
1 study in 21 results
-
Institutionalization (Institutionalized Persons)
:
1 study in 3 results
-
Exercise (Aerobic Exercise)
:
1 study in 2 results
-
Self-Help Devices (Assistive Technology)
:
4 results
-
Walking
:
3 results
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.